Adial Pharmaceuticals, Inc. (ADIL) Earnings

Adial Pharmaceuticals, Inc. is expected to report next earnings on August 12, 2026 (in NaN days), with a consensus EPS estimate of $-1.02. ADIL has beaten EPS estimates in 8 of its last 12 reported quarters (average surprise -0.2% over the last four).

Next earnings
Aug 12, 2026in NaN days
EPS est $-1.02 · Revenue est
Track record
Beat EPS in 8 of 12 quarters
Avg surprise -0.2% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
May 8, 2026$-2.73$-1.48+45.8%
Mar 10, 2026$-2.13$-3.75-76.1%
Nov 13, 2025$-2.25$-2.00+11.1%
Aug 13, 2025$-0.22$-0.18+18.2%
May 14, 2025$-0.50$-0.34+32.0%
Mar 4, 2025$-0.38$-0.15+60.5%
Apr 4, 2024$-0.76$-1.35-77.6%
Nov 14, 2023$-1.14$-1.14+0.0%
Aug 21, 2023$-1.50$-1.33+11.3%
May 12, 2023$-3.50$-2.75+21.4%
Nov 14, 2022$-4.50$-3.00+33.3%
Aug 16, 2022$-4.00$-4.00+0.0%

Source: company filings + earnings calendar. For informational purposes only — not investment advice.